Our study’s objectives were to assess the levels of anti-C3aR and anti-C5aR antibodies in various glomerular disorders, look for correlations between these antibodies and clinical information, and determine whether these antibodies would be a good fit for future research assessing their predictive value over the course of particular glomerular diseases. This evidence concerns the gene C3AR1 and glomerular disorder.